RENAISSANCE TECHNOLOGIES LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 1037389 NEW YORK, NY

Position in BEAM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$15,272,400

+$3,033,837 QoQ

Shares Held

445,000

-13.4% QoQ

Ownership

0.431%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#35

of 274 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. BEAM ranks #39 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,272,400	445,000	-13.4%	Shares	Sole	2026-08-13
2026-03-31	$12,238,563	513,578	+228.2%	Shares	Sole	2026-05-14
2025-12-31	$4,338,180	156,500	+1192.6%	Shares	Sole	2026-02-12
2025-03-31	$236,449	12,107	-47.1%	Shares	Sole	2025-05-14
2024-12-31	$568,093	22,907	-82.6%	Shares	Sole	2025-02-13
2022-12-31	$5,158,609	131,900	+85.0%	Shares	Sole	2023-02-13
2022-09-30	$3,396,732	71,300	-74.5%	Shares	Sole	2022-11-14
2022-06-30	$10,834,929	279,900	+1596.4%	Shares	Sole	2022-08-12
2021-06-30	$2,123,715	16,500	-56.7%	Shares	Sole	2021-08-13
2021-03-31	$3,049,524	38,100	—	Shares	Sole	2021-05-13
No filing history on record for this holder in this stock.